Monthly Update7 Nov 2025, 05:34 pm
Ganga Pharmaceuticals Ltd: No Deviation or Variation in Utilization of Funds Raised Through Equity Shares Upon Convertible Warrants
AI Summary
Ganga Pharmaceuticals Ltd has reported no deviation or variation in the utilization of funds raised through equity shares upon Convertible Warrants under Preferential Issue on July 17, 2025. The funds were raised for funding capital expenditure requirements, augmenting working capital needs, and general corporate purposes. As of September 30, 2025, there is an unutilized amount of Rs 53,48,145/-.
Key Highlights
- Ganga Pharmaceuticals Ltd raised Rs. 1,12,87,500 through equity shares upon Convertible Warrants on July 17, 2025.
- No deviation or variation in the utilization of funds has been reported.
- Funds were raised for funding capital expenditure requirements, augmenting working capital needs, and general corporate purposes.
- As of September 30, 2025, there is an unutilized amount of Rs 53,48,145/-.
- The company is in compliance with Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Price Impact
More from GANGAPHARM